BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
175 hedge funds and large institutions have $4B invested in Blueprint Medicines in 2018 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 55 increasing their positions, 63 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
175
Holders Change
+5
Holders Change %
+2.94%
% of All Funds
4.02%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.28%
New
31
Increased
55
Reduced
63
Closed
24
Calls
$16.4M
Puts
$16.3M
Net Calls
+$156K
Net Calls Change
-$13.1M
Top Buyers
| 1 |
AG
Artal Group
Luxembourg
|
$41.3M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
$29.1M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
$245M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
$20.9M |
| 5 |
BlackRock
New York
|
$299M |
